We incorporated the non-natural photoreactive amino acid p-benzoyl-L-phenylalanine (Bpa) into the RNA polymerase II (Pol II) surface surrounding the central cleft formed by the Rpb1 and Rpb2 subunits. Photo-cross-linking of preinitiation complexes (PICs) with these Pol II derivatives and hydroxyl-radical cleavage assays revealed that the TFIIF dimerization domain interacts with the Rpb2 lobe and protrusion domains adjacent to Rpb9, while TFIIE cross-links to the Rpb1 clamp domain on the opposite side of the Pol II central cleft. Mutations in the Rpb2 lobe and protrusion domains alter both Pol II-TFIIF binding and the transcription start site, a phenotype associated with mutations in TFIIF, Rpb9 and TFIIB. Together with previous biochemical and structural studies, these findings illuminate the structural organization of the PIC and the network of protein-protein interactions involved in transcription start site selection.
The earliest step in transcription initiation is recruitment of Pol II and the general transcription factors to form the PIC 1 . Upon addition of ATP, the PIC transitions to the open complex state, resulting in separation of the DNA strands surrounding the transcription start site and insertion of the template strand into the active center of Pol II. Next, Pol II must locate the transcription start site, which in Saccharomyces cerevisiae can be more than 60 base pairs away from the initial site of DNA strand separation 2 . Mutations in the general factor TFIIF and in the B-finger domain of the general factor TFIIB can alter the transcription start site, suggesting these two factors are involved in recognizing the start site [3] [4] [5] [6] [7] . Consistent with this role, crystallography and protein-protein cross-linking in the PIC have mapped the positions of both of these factors within the Pol II active site cleft [8] [9] [10] . Additionally, mutations in the Pol II subunit Rpb9 have been found to alter the transcription start site, but it remains unclear how this subunit, which is distant from the Pol II active site, participates in start site selection 11, 12 .
Initiation of RNA synthesis begins with DNA-NTP base pairing, phosphodiester bond formation and translocation of the DNA-RNA hybrid within the active center of Pol II. After synthesis of 8-12 bases of RNA, Pol II escapes from the promoter into a stable elongation state [13] [14] [15] . The nucleation of transcription factors at the promoter and the structural transition into the open and elongation complexes involve a complex set of protein-protein and protein-DNA interactions. Elucidating these molecular interactions within the transcription machinery is important for understanding the functional roles of the general transcription factors and the mechanisms of transcription regulation.
At the center of the transcription machinery, the 12-subunit Pol II enzyme contains two large subunits, Rpb1 and Rpb2, that form a central cleft for nucleic acid entry and contain the enzyme active site [16] [17] [18] . The remaining ten smaller subunits (Rpb3-Rpb12) surround these two largest subunits to provide structural support and to regulate Pol II enzymatic activity. Photo-cross-linking and hydroxyl radical-generating probes positioned on yeast TFIIB, in combination with structural studies, have suggested a model for PIC architecture where TFIIB, in combination with TFIIF, is positioned over the Pol II central cleft and wall domain 8, 9 (termed the 'flap' in bacterial Pol). TFIIB binding to this location in association with the TATA-binding protein (TBP)-DNA complex has been proposed to bend promoter DNA around Pol II and to position the promoter above the central cleft. In agreement with this model, a previous study using hydroxyl radical-generating probes linked to promoter DNA has suggested that the path of DNA lies above the central cleft 19 . Additionally, this study, along with earlier protein-DNA crosslinking studies in the human transcription system [20] [21] [22] [23] , suggests that TFIIF, TFIIE and TFIIH are positioned near the central cleft. Cryo-EM studies of the Pol II-TFIIF complex have suggested that TFIIF lies adjacent to the central cleft and the Rpb1 clamp domain 24 (termed the 'b¢ pincer' in bacterial Pol).
A limitation of our previous photo-cross-linking studies designed to probe the architecture of the PIC was that the photoprobe used was specific for incorporation at surface-exposed cysteine residues, requiring protein engineering to generate polypeptides with single surface cysteines. This approach is impractical for large multisubunit proteins and for proteins with essential cysteine residues. To overcome this limitation in the present work, we used a system that incorporates photoreactive non-natural amino acids in S. cerevisiae. We were thereby able to position short cross-linking probes on the Pol II surface surrounding the central cleft and to map the interactions of Pol II in the PIC with TFIIB, TFIIF and TFIIE. Our results reveal an unexpected location for Pol II-TFIIF binding that can explain the role of Rpb9 in transcription start site selection. We confirmed this TFIIF location by Pol II mutagenesis and biochemical analysis. Together, our results reveal a protein-protein interaction network within the PIC that is involved in the mechanism of transcription initiation and start site selection.
RESULTS

Insertion of a non-natural amino acid photo-cross-linker
To insert the photoreactive amino acid Bpa into components of the transcription machinery, we modified a previously developed system 25 that consists of a yeast-replicating plasmid expressing an Escherichia coli tRNA Tyr amber suppressor tRNA and the E. coli tyrosyl-tRNA synthetase selected to charge the suppressor tRNA with Bpa 26 (Fig. 1a,b) . In preliminary tests, we found that expression of the tRNA from this plasmid was poor, as it lacks a yeast Pol III promoter, and this limited the suppression efficiency of the system. To improve efficiency, we tested strong, medium and weak yeast Pol III promoters driving expression of the suppressor tRNA 27 . Whereas a strong promoter resulted in very slow growth of yeast, presumably owing to high levels of amber codon suppression, the medium-strength N(GTT)PR promoter allowed expression of nearly normal levels of several proteinBpa derivatives under the conditions described below.
To validate this approach for examining protein-protein interactions within the PIC, we first inserted Bpa at a position in the TFIIB zinc-ribbon domain (Ser53) that was shown in our previous study 8 to cross-link to the Rpb1 clamp domain and is positioned near Rpb1 in the TFIIB-Pol II crystal structure 10 (Fig. 1c) . We constructed a yeast strain containing a deletion of the chromosomal copy of TFIIB, a plasmid encoding TFIIB with a TAG codon at the position corresponding to amino acid residue 53, and the plasmid pLH157 encoding the modified suppressor tRNA Tyr and Bpa-tRNA synthetase (Fig. 1a) . As TFIIB is an essential protein, the strain grew only when Bpa was supplied in the medium. Nuclear extracts were prepared both from this strain and from a control strain containing no amber mutation in the TFIIB plasmid (wild type). PICs were formed and isolated by incubating the nuclear extract with promoter templates immobilized on magnetic beads. These PICs were irradiated with UV light and the products analyzed by SDS-PAGE and western blotting. A slowly migrating band was observed only when PICs formed using TFIIB Ser53-Bpa were treated with UV light (Fig. 1d) . This slowly migrating polypeptide contains both Rpb1 and TFIIB, as demonstrated by western blotting (Fig. 1d, lanes 4 and 8) , and is therefore a product of cross-linking between TFIIB and Rpb1. This experiment validates the use of this system for inserting a site-specific photoreactive probe into the PIC. Unlike the cysteine-specific incorporation of biochemical probes used for small proteins such as TFIIB, TFIIA and activation domains in our previous experiments 8, [28] [29] [30] , this method is applicable to large polypeptides containing multiple cysteines and to subunits of large protein complexes (see below), as long as protein function is not compromised by Bpa insertion.
The Rpb2 wall cross-links to the TFIIB core domain Previous site-specific biochemical probing using cysteine-specific photo-cross-linking and hydroxyl-radical cleavage reagents allowed us to map the TFIIB core domain to a position over the central cleft and wall domain of Rpb2 (ref. 9 and Fig. 2a) . To further investigate proteins targeting the wall domain and to confirm our previous model, we used the non-natural Bpa incorporation system to insert Bpa at four locations on the wall surface (Fig. 2a) . For these experiments, a yeast strain was constructed analogous to that described for Figure 1a , except that the chromosomal copy of RPB2 was disrupted and the amber plasmid contained the Rpb2-coding sequence with a TAG mutation at each of the indicated positions. These strains also required Bpa in their media for growth. Nuclear extracts prepared from these strains were used for PIC formation, irradiated with UV light and analyzed by western blotting. Bpa incorporated in place of Tyr866 or Ser919 cross-linked to Rpb1 (Fig. 2b, lanes 6 and 8) , consistent with the locations of these two residues near Rpb1 in the Pol II structure (Fig. 2a) . We determined the identity of this Rpb1-Rpb2 cross-linked product by probing a duplicate western blot with Rpb1 antibody, revealing an identical mobility shift in Rpb1 (Fig. 2c, lanes 2 and 4) . We also found that Bpa residues substituted for Rpb2 Val108, Asn103, Tyr866 and Ser919 all cross-linked to TFIIB (Fig. 2b, lanes 2, 4, 6 and 8 ). The identity of the cross-linked product was confirmed as above, by showing that this cross-linked product reacted with antisera directed against both Rpb2 and TFIIB (Fig. 2d, lanes 2 and 4 , and data not shown).
Whereas the positions of Asn103, Ser919 and Tyr866 in Rpb2 are all adjacent to the TFIIB core domain in our previous PIC models, the location of Rpb2 Val108 is approximately 10 Å outside the permissible cross-linking range for Bpa. Further movement of the core domain to a position closer to Val108 is prevented in the current model, which uses the structure of the elongating form of Pol II. In this model, we positioned the TFIIB core domain by docking the structure of the Mapping the binding sites for TFIIF and TFIIE on Pol II As described above, previous studies have indicated that the face of Pol II containing the central cleft is likely to be in close contact with subunits of general factors, including TFIIF and TFIIE. To map these interactions, we first incorporated Bpa into positions in the Rpb2 lobe and protrusion domains ( Fig. 3 ) and used the resulting derivatives for cross-linking in isolated PICs. Bpa incorporated in these domains of Rpb2 extensively cross-links to other polypeptides in PICs (Fig. 3a) . To identify these cross-linked polypeptides, we repeated the experiment with added recombinant TFIIF in which the large TFIIF subunit (Tfg1) was tagged with a Flag epitope. Western analysis of these cross-linking reactions with anti-Flag sera showed that almost all the substituted Rpb2 positions cross-link to Tfg1 ( Fig. 3b and Supplementary Fig. 1 online). In addition, probing the cross-linking reactions with antibody to the TFIIF small subunit (anti-Tfg2) showed that Rpb2 Tyr57 crosslinks to Tfg2 ( view of TFIIF interaction on the Pol II surface, compared with the cryo-EM study of Pol II-TFIIF 24 . In the latter study, Tfg2 was proposed to be present mainly in the Pol II central cleft, with much of the Tfg1 density located near the Pol II clamp domain.
To examine interactions with the clamp domain, the Bpa photocross-linker was incorporated into Rpb1 on the opposite side of the central cleft from the Rpb2 lobe and protrusion domains (Fig. 4a) . Rpb1 His213 and His286 were found to cross-link to Tfa2 and Tfa1, respectively, subunits of the heterodimeric TFIIE (Fig. 4b-d) . Western analysis confirmed these cross-linked polypeptides as Tfa1 and Tfa2 (Fig. 4c,d ). Rpb1 His213 and His286 are both located at the edge of the clamp domain.
Rpb1 Asn64 cross-links to a large polypeptide that we presume to be Rpb2, given the proximity of Asn64 to Rpb2 in the Pol II structure (Fig. 4b, lane 8 , labeled 'Rpb1 + Rpb2?'). Although most positions of Bpa incorporation in the clamp domain showed no detectable crosslinking (data not shown), three positions (Thr278, His286, Asn64) each showed cross-linking to a polypeptide that we have not yet identified (Fig. 4b , lanes 4, 6 and 8, asterisks). We have confirmed that this cross-linked polypeptide is not Tfa1 or Tfg2. In the Pol II-TFIIF cryo-EM structure 24 , one structural fragment of Tfg2 is proposed to contact the edge of the clamp domain, and a large fragment of Tfg1 occupies the space between the bottom of the clamp and the Rpb4-Rpb7 dimer. However, none of our Bpa positions on the clamp crosslinked with these two TFIIF subunits. In particular, Bpa positions on the bottom of the clamp, including Rpb1 Ala29 and Val227 and Rpb2 His1177 (Fig. 4a) , yielded no detectable cross-linking.
Mutations in the Rpb2 lobe and protrusion domains
The finding that TFIIF extensively contacts the Rpb2 lobe and protrusion domains led us to test the contribution of this interaction to transcription initiation. Previous studies have identified mutations in this Rpb2 area that affect the accuracy of transcription initiation 5, 33 . We generated yeast strains containing mutations on the surface of the Rpb2 lobe and protrusion domains. Several mutations near the positions that cross-linked to TFIIF (purple in Fig. 5a ) were lethal (blue) or caused slightly slow growth at nonpermissive temperatures (orange). To determine whether these mutations affect Pol II-TFIIF Positions of Rpb2-Bpa cross-linked to TFIIF ( Fig. 3 ; Tfg1 and Tfg2) and TFIIB (Fig. 2) binding, we conducted a coimmunoprecipitation experiment. We used anti-Flag agarose beads to purify Flag epitope-tagged Pol II variants with Rpb2 mutations and tested for coprecipitation of TFIIF. Results were quantified by measuring the ratio of coprecipitated Rpb1 (from Pol II) and Tfg2 (from TFIIF). Three Rpb2 mutations substantially decreased binding between TFIIF and Pol II, with Rpb2 F322R and G369R each reducing Tfg2 coprecipitation three-to fourfold (Fig. 5b) . To our surprise, three Rpb2 mutations changing glutamate to arginine at positions 328, 368 and 371 all increased the association of Tfg2 with Pol II. Although we did not expect to find mutations that increased the affinity of TFIIF for Pol II, the fact that six mutations on the lobe and protrusion domain surfaces all altered the interaction of Pol II with TFIIF supports the cross-linking studies indicating that TFIIF binds Pol II in this location. The ability of these Rpb2 derivatives to form stable PICs was further assessed by using nuclear extracts to form PICs on immobilized promoter templates (Fig. 5c) . Extracts prepared from these mutants all formed normal amounts of PICs, suggesting that interactions among the other PIC components compensate for mutations that reduce Pol II-TFIIF binding. As experiments using DNA probes indicate that TFIIF lies near promoter DNA both upstream and downstream of the TATA box 19 , it is also possible that in the PIC, Tfg1 and Tfg2 interact with other surfaces of Pol II in addition to the lobe and protrusion domains, reducing the effects of the Rpb2 mutations. The transcriptional phenotypes of these Pol II mutants were also determined. Notably, all the mutations generate an upstream shift of the transcription start site in the yeast HIS4 promoter (Fig. 5d) . In wild-type extracts, the downstream start site is preferred over the upstream start site by approximately two-fold. In contrast, all the mutants prefer the upstream start site, showing at least a five-fold change in the relative use of this site. This result indicates that these mutations affect a step after PIC formation that involves selection of the transcription start site.
TFIIF dimerization domain contacts Rpb2 lobe and protrusion
The two largest subunits of yeast TFIIF, Tfg1 and Tfg2, are homologous to the RAP74 and RAP30 subunits of human TFIIF. The smallest yeast TFIIF subunit, Tfg3, is not conserved with metazoan TFIIF, is not essential for yeast growth and is also a subunit of yeast TFIID and chromatin remodeling complexes such as Swi/Snf and Ino80. RAP74 and RAP30 form a b-barrel dimerization fold with their respective N-terminal domains 34 . According to a sequence alignment, the N-terminal domains of Tfg1 and Tfg2 also contain conserved sequence blocks that are likely to form a heterodimeric structure similar to the RAP74-RAP30 b-barrel ( Supplementary Fig. 2 online) . A previous report has described mutations in Tfg1 and Tfg2 that cause transcription start site shifts similar to those seen with the Rpb2 lobe and protrusion domain mutants 6, 7 . These TFIIF mutations are located within the predicted dimerization regions of Tfg1 and Tfg2. As the similarity between yeast and human Tfg1 is weak, we directly tested whether the region of Tfg1 encompassing the mutations that affect transcription start site is required for TFIIF dimerization. Cotranslation of Tfg1 residues 1-424 and Tfg2 residues 1-230 allowed coprecipitation of Tfg1 with Tfg2 ( Supplementary Fig. 3 online) . In contrast, Tfg1 residues 1-375 or shorter derivatives did not coprecipitate with Tfg2, showing that the Tfg1 dimerization domain extends between residue 375 and 424 and supporting the alignment shown in Supplementary Fig. 2 .
To test whether this dimerization region is responsible for binding the Rpb2 lobe and protrusion domains, we used a hydroxyl-radical cleavage assay where iron (S)-1-(p-bromoacetamidobenyl)EDTA probes (FeBABE) were attached to Tfg1 near the Tfg1 positions whose mutation alters start site selection. To accomplish this, we generated recombinant TFIIF derivatives lacking all endogenous cysteine residues and harboring an inserted cysteine residue at one of seven positions ( Supplementary Figs. 2 and 4 online) . FeBABE was attached to the seven TFIIF derivatives as described 8 , and all modified proteins were functional in a transcription assay ( Supplementary  Fig. 4 ). These proteins were added to nuclear extracts containing Flag epitope-tagged Rpb2 or Rpb1, and PICs were formed and isolated on immobilized promoter templates. Hydroxyl-radical cleavage was activated by addition of peroxide and a reducing agent, and the products of the reaction were analyzed by western blotting (Fig. 6a,b) . The cleavage sites were identified by a previously described method 8 , using in vitro-translated Flag-tagged Rpb2 and Rpb1 peptides as molecularweight standards ( Supplementary Figs. 5 and 6 online) , and the results were mapped on the Pol II structure ( Fig. 6c; cleavage; light blue, weaker cleavage). We observed extensive cleavage on the Rpb2 lobe and protrusion domains, closely approaching the position of Rpb9, as well as cleavage in the Rpb1 jaw region (Fig. 6c) . These results, combined with the data presented above, indicate that the TFIIF dimerization domain interacts with the Rpb2 lobe and protrusion domains, where it mediates transcription start site selection. As TFIIF binds adjacent to Rpb9, we propose that mutations in Rpb9 that alter the transcription start site 11, 12 do so because of altered interactions with TFIIF.
DISCUSSION
Using site-specific incorporation of a short photoreactive amino acid, we have mapped the binding locations of TFIIB, TFIIF and TFIIE on the surface of Pol II. TFIIF and TFIIE are located on opposite sides of the Pol II central cleft, in position to affect post-recruitment steps in transcription initiation. Previously, we proposed a model for the binding of TFIIA-TFIIB-TBP-DNA on Pol II based on photo-crosslinking by probes attached to TFIIB, hydroxyl radical generation by probes attached to TFIIB and promoter DNA, and structural studies of these factors [8] [9] [10] 19, 31, 32, 35, 36 (Fig. 7a) . Our new findings demonstrate that in the PIC, the TFIIF dimerization domain interacts with the Rpb2 lobe and protrusion domains, while TFIIE makes close contacts with the Rpb1 clamp domain (Fig. 7a,b) . These results were unexpected, as the previous cryo-EM structure model for the Pol II-TFIIF complex proposed that TFIIF binds mainly the central cleft and clamp regions of Pol II 24 . Our studies found no evidence for a direct interaction of TFIIF with the clamp domain; however, our mapping of TFIIF and TFIIE is consistent with the positioning of these factors based on protein-DNA cross-linking and hydroxyl-radical cleavage assays 19, 20, 23 . As described below, this positioning of TFIIF can explain how mutations very distant from the Pol II active site can affect transcriptional start site selection.
Our results, taken together with previous findings, show the close interaction of the general factors poised over the active site cleft, where they probably cooperate in post-recruitment steps. Biochemical assays have demonstrated that TFIIB, TFIIF and TFIIE bind Pol II directly 37 . The structure of the TFIIB-Pol II complex shows that the TFIIB B-finger domain is located within the active site cleft of Pol II 10 . Studies using photo-cross-linkers positioned on the TFIIB B-finger, linker and core domains have shown that these regions are in close proximity to TFIIF in the PIC, locating part of TFIIF within the active site cleft 9 . Our present results show that the TFIIF dimerization domain is positioned above the cleft, adjacent to Rpb9 and directly across the cleft from TFIIE. Previous experiments have shown that the TFIIH helicase XPB (Rad25 in yeast) is located near the promoter DNA, just downstream from TFIIE 19, 23 . Thus, the combined results reveal the close association of TFIIB, TFIIF, TFIIE and XPB and suggest that protein-protein interactions between these factors are important in post-recruitment steps. These steps would involve initial melting of the promoter DNA strands, insertion of the single-stranded template into the active site of Pol and translocation of the template strand through the active site of the enzyme until the transcription start site is recognized.
Mutations in TFIIB, TFIIF, Rpb1, Rpb2 and Rpb9 that alter the accuracy of transcription start site selection have all been identified genetically 3, 4, 6, 7, 11, 33, 38 . It has been difficult to explain how mutations in the Rpb2 lobe and protrusion domains and Rpb9 (Figs. 5-7) , located distant from the Pol II active site, could affect this process. Our present results, in combination with previous studies, suggest that these factors are all connected by a protein-protein interaction network extending from the Pol II Rpb1-Rpb9 jaw into the active site. Rpb9 is adjacent to TFIIF, and part of TFIIF is in the active site cleft adjacent to the TFIIB B-finger. We suggest that mutations in Rpb2 and Rpb9 affect the conformation of TFIIF and/or its activity in transcription start site selection. As TFIIF is closely associated with the TFIIB B-finger, and it has been proposed that the B-finger recognizes the initiation sequence in the template strand, it is possible that TFIIF could directly or indirectly influence this DNA sequence recognition or that TFIIB could function indirectly by influencing TFIIF activity. Notably, mutations in TFIIF, Rpb9 and Rpb2 have opposite effects compared with mutations in Rpb1 and TFIIB. The TFIIF, Rpb9 and Rpb2 mutations cause Pol II to select transcription start sites further upstream, whereas the Rpb1 and TFIIB mutations cause Pol II to Figure 7 Model of PIC assembly. (a) Model of complex showing TFIIB core domain (TFIIBc) binding to Pol II deduced from previous biochemical analyses and non-natural amino acid photo-cross-linking in this study. TFIIA, TBP and DNA are fit into the complex on the basis of the crystal structures of human TFIIB core (TFIIBc)-TBP-TATA box ternary complex (PDB 1C9B) 32 and yeast TFIIA-TBP-TATA box complex (PDB 1RM1) 35 . TFIIB ribbon domain is modeled onto the Pol II surface on the basis of the Pol II-TFIIB cocrystal (PDB 1R5U) 10 : magenta sphere, zinc atom; yellow and green backbones, TFIIB and TBP, respectively; orange and magenta backbones, Toa1 and Toa2 subunits of TFIIA, respectively. The DNA strands flanking the TATA box (recognized by TBP) are extended from the human ternary complex structure using straight B-form DNA, and comprise positions -47 to +18 (numbering based on the adenovirus major late promoter, where +1 is transcription start and TATA box sequence starts at -31). Nontemplate and template strands are colored pink and light blue, respectively; red and dark blue highlight DNA base pair -12, the site of prefer start sites further downstream. Understanding the effects of these mutations and the mechanism of transcription start site selection will require further biochemical and structural studies.
A model for initiation that is consistent with our results and with previous findings 19 is the following. After PIC formation, torsional strain in promoter DNA caused by the XPB helicase would allow insertion of residues from TFIIF, TFIIE or both into promoter DNA to initiate and stabilize formation of the single-stranded bubble. This would lead to insertion of the single-stranded DNA into the active site of the enzyme by an as yet unknown mechanism. In a mechanism somewhat analogous to the model proposed for bacterial RNA polymerase 'scrunching' 39, 40 , single-stranded DNA would be fed through the active site of Pol II while it was still situated at the promoter and associated with the other general factors, until a suitable initiation sequence was encountered. Unlike the bacterial scrunching mechanism, the movement of single-stranded DNA is probably not driven by abortive initiation; rather, it could be mediated by the helicase and ATP hydrolysis. The initiation site may be recognized by segments of TFIIB, TFIIF and Pol II, leading to transcription start site recognition. For the polymerase to transition to the productive elongation mode, at a minimum, the B-finger must exit from the RNA exit channel to allow elongation and exit of the growing RNA chain from Pol II 15 . In addition, Pol II must break its contacts with the general factors and promoter DNA so that it can begin moving into the coding sequence of the gene. Delineating more details of this process and testing aspects of the model will require trapping the initiation complex at intermediate states to allow structural and biochemical characterization of individual steps in the initiation process.
METHODS
Yeast plasmids, strains and antisera. Plasmids, strains and antisera used for this study are listed in the Supplementary Methods online.
Yeast nuclear extracts and in vitro transcription assay. Yeast nuclear extracts and in vitro transcription assays were done as described 41 . To grow yeast culture in YPD medium containing Bpa (Bachem), we added 2.5 ml Bpa (100 mM in 1M HCl) and an equal volume of 1 M NaOH to each liter of YPD before inoculation with a saturated culture.
PIC isolation and photo-cross-linking. The immobilized template assay for PIC formation was done as described 41 . Gal4-VP16 and nuclear extracts prepared from the amber strain grown in medium containing Bpa were used to assemble PICs on immobilized DNA templates containing the yeast HIS4 promoter and a single upstream Gal4-binding site. After washing to remove nonspecifically bound protein, UV irradiation was applied to the immobilized PICs in a Spectrolinker XL-1500 UV oven (Spectronics) with a total energy of 15,000 mJ cm -2 (B5 min). The UV-irradiated PICs were analyzed by SDS-PAGE and western blotting.
Identification of the cross-linking target. Identification of the cross-linking target using western analysis was based on visualization of a protein band simultaneously responsive to antibodies against the Bpa-carrying protein and the cross-linked polypeptides. For example, TFIIB-specific antibody (rabbit polyclonal) and Rpb1 CTD-specific antibody (mouse monoclonal, 8WG16) were used for the TFIIB-Bpa study, in which the western blot was visualized with fluorescent dye-labeled secondary antibodies against the respective primary antibodies (Fig. 1d) . Similarly, Myc-specific antibody was used to reveal Myc epitope-tagged Rpb2 in the Rpb2-Bpa cross-linking study, and the cross-linked polypeptides Rpb1, TFIIB and Tfg2 were identified with the respective polyclonal antibodies (Fig. 2 and Fig. 3c ). The same strategy was applied to identify Rpb1-Tfa2 cross-linking using anti-Myc (Rpb1) and antiTfa2 (Fig. 4d) . For identification of a cross-linking target such as Tfg1 that has no polyclonal antiserum, two mixing methods were used. In the first method, the recombinant TFIIF (320 ng) containing Flag epitope-tagged Tfg1 (see below) was added into the nuclear extract (480 mg) of Rpb2 amber strain and used in the immobilized template assay and photo-cross-linking. The resulting sample was analyzed by western blotting using Flag-specific antibody to confirm the identity of the cross-linked protein Tfg1 (Fig. 3b) . In the second method, the nuclear extract containing the Flag epitope-tagged Tfg1 was premixed with the nuclear extract of the Rpb2 amber strain in a 1:1 ratio, giving a total of 480 mg of proteins in the immobilized template assay, which was followed by photo-cross-linking and western analysis using anti-Flag to identify Tfg1 (Supplementary Fig. 1 ). This nuclear extract mixing method was also applied to validate Rpb1-Tfa1 cross-linking (Fig. 4c) .
TFIIF mutant plasmids. To circumvent problems with the cloning and expression of the S. cerevisiae TFG1 gene, the gene encoding Saccharomyces mikatae Tfg1 (which completely complements TFG1 function in S. cerevisiae) was amplified by PCR using genomic DNA prepared from S. mikatae, and the resulting 2.7-kilo-base-pair (kbp) DNA fragment was cloned through A-tail ligation into the pETSUMO vector (Invitrogen), with a SUMO protease cleavage site inserted before the codon for S. mikatae Tfg1 (SmTfg1) residue 1. Subsequently, the 3.1-kbp Sph1I-SacI DNA fragment encoding His 6 -SUMOSmTfg1 was subcloned into the pETDuet-1 vector (Novagen). The 1.2-kbp PCR-generated S. cerevisiae TFG2 DNA fragment (encoding ScTfg2) was then cloned into the second polylinker region, between the XhoI and AvrII sites. The resulting plasmid was subjected to oligonucleotide-directed phagemid mutagenesis 42 to mutate all endogenous cysteines in both SmTfg1 and ScTfg2 to noncysteine residues. The resulting plasmid, pHCf601, encodes the mutant proteins SmTfg1 C611S C717S and ScTfg2 C219A C222A C322S. All cysteine substitutions in the Tfg1 dimerization domain were generated using phagemid mutagenesis of pHCf601.
Coimmunoprecipitation of Tfg1 and Tfg2 dimerization domain fragments.
Flag-tagged SmTfg1 and untagged ScTfg2 N-terminal peptide fragments were generated by in vitro translation using PCR-generated DNA templates and reticulocyte lysate (TNT T7 Quick; Promega). Each set of SmTfg1 and ScTfg2 polypeptides ( Supplementary Fig. 3c ) was coexpressed in 50-ml coupled T7 transcription and translation reactions. The in vitro-translation products were mixed with 20 mg anti-Flag M2 affinity gel (Sigma) pre-equilibrated with potassium acetate transcription buffer (100 mM potassium acetate final concentration, 0.1% (w/v) BSA, 0.05% (v/v) Nonidet P-40 (NP-40)) and was incubated at 4 1C for 2 h. The anti-Flag gel beads with bound TFIIF peptide fragments were washed three times with 400 ml transcription buffer lacking BSA. Immunoprecipitated TFIIF peptide fragments were eluted with 100 ml 1 mg ml -1 triple-Flag peptide (Sigma), precipitated with trichloroacetic acid (final concentration 10% (v/v)) and analyzed by western blotting using the LI-COR Bioscience Odyssey infrared imaging system. TFIIF purification. TFIIF was purified as detailed in Supplementary Methods. Attachment of protein cleavage reagent FeBABE. The procedure for labeling the TFIIF cysteine mutants with FeBABE (Dojindo) was similar to that described 8 for TFIIB. TFIIF mutant samples were first subjected to a procedure to remove DTT present in the purification buffer using a NAP-5 desalting column (GE Healthcare), then incubated with FeBABE. Unincorporated FeBABE was removed using a second NAP-5 column. Labeled samples were frozen and stored at -70 1C until use in hydroxyl-radical assays. Labeling and sample-storage buffer contained 300 mM potassium acetate, 10% (v/v) glycerol and 20 mM Tris (pH 7.8).
Hydroxyl-radical cleavage and determination of FeBABE cleavage sites. Hydroxyl-radical probing experiments were conducted using the method described in previous TFIIB work 8 . Yeast nuclear extracts, Gal4-VP16 activator and FeBABE-conjugated TFIIF cysteine mutants were subjected to the Pol II immobilized template assay to form PICs on DNA templates attached to magnetic beads (see above). The amount of FeBABE-conjugated TFIIF used in a 100-ml PIC formation assay was 800 ng. After PIC formation on immobilized templates, iron-EDTA was activated to generate hydroxyl radicals as described 8 . Cleavage fragments were visualized using western blotting and the LI-COR Bioscience Odyssey infrared imaging system. Accurate determination of the sizes of FeBABE cleavage fragments and the corresponding cut sites within proteins has been described 8 . For each calculated cut site, a range of 9 amino acid residues (centered at the cut site) was highlighted on the Pol II surface, reflecting the estimated precision of the molecular size determination.
Pol II-TFIIF binding assay. Nuclear extracts from yeast strains containing wild-type or mutant Rpb2 with a C-terminal Flag tag were used for immunoprecipitation. Nuclear extract (480 mg) was mixed with 20 mg anti-Flag M2 affinity gel (Sigma) in 100 ml potassium acetate transcription buffer containing BSA and NP-40 (see above), and incubated at 4 1C for 2 h. Immunoprecipitated Pol II was washed three times with 400 ml of the same transcription buffer, then washed three more times with 400 ml of transcription buffer containing 550 mM potassium acetate and 0.05% (v/v) NP-40. The anti-Flag gel beads with bound Pol II-TFIIF complex were eluted with 100 ml 1 mg ml -1 triple-Flag peptide (Sigma) and precipitated with trichloroacetic acid (final concentration 10% (v/v)). Polypeptides retained from coimmunoprecipitation were analyzed by western blotting and visualized using the LI-COR Bioscience Odyssey infrared imaging system. Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
